0001387131-22-012291.txt : 20221209
0001387131-22-012291.hdr.sgml : 20221209
20221209182247
ACCESSION NUMBER: 0001387131-22-012291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221206
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zanganeh Mahkam
CENTRAL INDEX KEY: 0001507650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 221455839
MAIL ADDRESS:
STREET 1: 51 ADAM WAY
CITY: ATHERTON
STATE: CA
ZIP: 94027
FORMER NAME:
FORMER CONFORMED NAME: Zanganeh Maky
DATE OF NAME CHANGE: 20101210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
zangeneh-form4_120622.xml
X0306
4
2022-12-06
0
0001599298
Summit Therapeutics Inc.
SMMT
0001507650
Zanganeh Mahkam
51 ADAM WAY
ATHERTON
CA
94027
1
1
0
0
Co-CEO & President
Common Stock
2022-12-06
4
J
0
373857
A
10930849
D
373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79.
/s/ Mahkam Zanganeh
2022-12-09